1. Scrip
  2. >>Business
  3. >>Deals

Merck & Co and Schering-Plough settle shareholder lawsuits over merger disclosures

 
• By Sue Sutter

Merck & Co and Schering-Plough have settled shareholder class action lawsuits seeking to block the companies' planned merger.

Merck & Co and Schering-Plough have settled shareholder class action lawsuits seeking to block the companies' planned merger.

Under the proposed settlements, Merck and Schering-Plough made additional disclosures related to the deal, in which Merck would acquire Schering-Plough for cash and stock valued at $41 billion. Neither company...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Deals

More from Business

Gilead Ready To Go After Hepatitis D Again

 
• By Joseph Haas

Following an FDA complete response in 2022, Gilead is getting ready to refile bulevirtide for hepatitis D. The drug already is approved in the EU, UK and elsewhere.

Progress In The Effort To Improve Outcomes In SCLC

 
• By Jessica Merrill

Several drug makers are working to bring new advances to small-cell lung cancer, a fast-growing cancer with limited treatment options.

Stock Watch: Q1 Sales Trends And Forex Muddle Pharma Outlook

 
• By Andy Smith

Pharma firms tended to downplay first-quarter trends in full-year guidance. However, raised guidance seems fragile amid ongoing foreign exchange effects and Medicare Part D redesign pressures.